SEARCH
= Registered usersPractitioner 2011; 255 (1739): 10
5-α reductase inhibitors may delay the progression of low-grade prostate cancer
20 Apr 2011
Giving 5-alpha reductase inhibitors (5-ARIs) to men with low-risk prostate cancer undergoing active surveillance was associated with a lower rate of pathologic progression in a small retrospective cohort study.
This article can be accessed only if you are a paid-up subscriber to The Practitioner.